In another placebo-controlled study, the primary endpoint of pain reduction could not be reached after eight weeks, but the post hoc analysis showed a trend towards significantly more time in the “reduced pain state” with the higher dosage of 500 U abobotulinum toxin A after 12 weeks [ 18 , 19 ]. 3.
1
—
—